My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 253

    1.

    Plasma levels of tumor necrosis factor-alpha, angiotensin II, growth hormone, and IGF-I are not elevated in insulin-resistant obese individuals with impaired glucose tolerance.

    Blüher M, Kratzsch J, Paschke R.

    Diabetes Care. 2001 Feb;24(2):328-34.PMID: 11213887 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Soluble tumor necrosis factor-alpha receptors in young obese subjects with normal and impaired glucose tolerance.

    Dzienis-Straczkowska S, Straczkowski M, Szelachowska M, Stepien A, Kowalska I, Kinalska I.

    Diabetes Care. 2003 Mar;26(3):875-80.PMID: 12610052 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The serum concentration of tumor necrosis factor alpha is not an index of growth-hormone- or obesity-induced insulin resistance.

    Pincelli AI, Brunani A, Scacchi M, Dubini A, Borsotti R, Tibaldi A, Pasqualinotto L, Maestri E, Cavagnini F.

    Horm Res. 2001;55(2):57-64.PMID: 11509860 [PubMed - indexed for MEDLINE]Related articles

    4.

    Relationship between plasma leptin levels and the tumor necrosis factor-alpha system in obese subjects.

    Corica F, Allegra A, Corsonello A, Buemi M, Calapai G, Ruello A, Nicita Mauro V, Ceruso D.

    Int J Obes Relat Metab Disord. 1999 Apr;23(4):355-60.PMID: 10340812 [PubMed - indexed for MEDLINE]Related articles

    5.

    Changes in tumor necrosis factor-alpha system and insulin sensitivity during an exercise training program in obese women with normal and impaired glucose tolerance.

    Straczkowski M, Kowalska I, Dzienis-Straczkowska S, Stepién A, Skibińska E, Szelachowska M, Kinalska I.

    Eur J Endocrinol. 2001 Sep;145(3):273-80.PMID: 11517007 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.

    Pratipanawatr T, Pratipanawatr W, Rosen C, Berria R, Bajaj M, Cusi K, Mandarino L, Kashyap S, Belfort R, DeFronzo RA.

    Am J Physiol Endocrinol Metab. 2002 Jun;282(6):E1360-8.PMID: 12006367 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects.

    Santomauro AT, Boden G, Silva ME, Rocha DM, Santos RF, Ursich MJ, Strassmann PG, Wajchenberg BL.

    Diabetes. 1999 Sep;48(9):1836-41.PMID: 10480616 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Short-term low-dose growth hormone administration in subjects with impaired glucose tolerance and the metabolic syndrome: effects on beta-cell function and post-load glucose tolerance.

    Yuen K, Wareham N, Frystyk J, Hennings S, Mitchell J, Fryklund L, Dunger D.

    Eur J Endocrinol. 2004 Jul;151(1):39-45.PMID: 15248820 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Plasma levels of soluble tumor necrosis factor-alpha receptors are related to total and LDL-cholesterol in lean, but not in obese subjects.

    Straczkowski M, Kowalska I, Nikolajuk A, Adamska A, Karolczuk-Zarachowicz M, Karczewska-Kupczewska M, Kozlowska A, Gorska M.

    Cardiovasc Diabetol. 2006 Jun 27;5:14.PMID: 16803616 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin.

    Willi SM, Kennedy A, Wallace P, Ganaway E, Rogers NL, Garvey WT.

    Diabetes. 2002 Oct;51(10):2895-902.PMID: 12351424 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Mechanisms of insulin resistance in cystic fibrosis.

    Hardin DS, Leblanc A, Marshall G, Seilheimer DK.

    Am J Physiol Endocrinol Metab. 2001 Nov;281(5):E1022-8.PMID: 11595659 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.

    Chavez AO, Molina-Carrion M, Abdul-Ghani MA, Folli F, Defronzo RA, Tripathy D.

    Diabetes Care. 2009 Aug;32(8):1542-6. Epub 2009 Jun 1.PMID: 19487637 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Tumor necrosis factor alpha -238G>A genotype alters postprandial plasma levels of free fatty acids in obese individuals with type 2 diabetes mellitus.

    Fontaine-Bisson B, Wolever TM, Chiasson JL, Rabasa-Lhoret R, Maheux P, Josse RG, Leiter LA, Rodger NW, Ryan EA, El-Sohemy A.

    Metabolism. 2007 May;56(5):649-55.PMID: 17445540 [PubMed - indexed for MEDLINE]Related articles

    14.

    Serum levels of soluble tumor necrosis factor-alpha receptor 2 are linked to insulin resistance and glucose intolerance in children.

    Gupta A, Ten S, Anhalt H.

    J Pediatr Endocrinol Metab. 2005 Jan;18(1):75-82.PMID: 15679072 [PubMed - indexed for MEDLINE]Related articles

    15.

    Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT.

    Stefan N, Stumvoll M, Bogardus C, Tataranni PA.

    Am J Physiol Endocrinol Metab. 2003 Jun;284(6):E1156-61. Epub 2003 Feb 11.PMID: 12582008 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.

    Miyazaki Y, Mahankali A, Wajcberg E, Bajaj M, Mandarino LJ, DeFronzo RA.

    J Clin Endocrinol Metab. 2004 Sep;89(9):4312-9.PMID: 15356026 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Discrepancies in the regulation of plasma adiponectin and TNF-alpha levels and adipose tissue gene expression in obese African Americans with glucose intolerance: a pilot study using rosiglitazone.

    Osei K, Gaillard T, Cook C, Kaplow J, Bullock M, Schuster D.

    Ethn Dis. 2005 Autumn;15(4):641-8.PMID: 16259488 [PubMed - indexed for MEDLINE]Related articles

    18.

    Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.

    Leiter LA, Lewanczuk RZ.

    Am J Hypertens. 2005 Jan;18(1):121-8. Review.PMID: 15691626 [PubMed - indexed for MEDLINE]Related articles

    19.

    Increased plasma-soluble tumor necrosis factor-alpha receptor 2 level in lean nondiabetic offspring of type 2 diabetic subjects.

    Straczkowski M, Kowalska I, Stepien A, Dzienis-Straczkowska S, Szelachowska M, Kinalska I.

    Diabetes Care. 2002 Oct;25(10):1824-8.PMID: 12351485 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.

    Miyazaki Y, Pipek R, Mandarino LJ, DeFronzo RA.

    Int J Obes Relat Metab Disord. 2003 Jan;27(1):88-94.PMID: 12532159 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity